Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.55%1.65B | 10.81%6.26B | 10.69%1.59B | 6.92%1.5B | 11.21%1.6B | 14.43%1.56B | 0.90%5.65B | 12.43%1.44B | 2.07%1.41B | -1.73%1.44B |
| Net interest income | 1.49%1.03B | 4.34%3.99B | 4.16%1.02B | -0.63%962.96M | 4.49%992.67M | 9.59%1.01B | 3.74%3.82B | 9.83%981.06M | 14.46%969.03M | -0.48%950.03M |
| -Total interest income | 0.27%2.26B | 1.20%8.89B | 0.21%2.25B | -1.86%2.17B | 1.16%2.2B | 5.50%2.25B | 16.63%8.78B | 10.52%2.24B | 16.11%2.21B | 15.43%2.17B |
| -Total interest expense | -0.72%1.23B | -1.21%4.9B | -2.86%1.22B | -2.83%1.21B | -1.43%1.21B | 2.40%1.24B | 28.98%4.96B | 11.05%1.26B | 17.44%1.24B | 31.77%1.22B |
| Non interest income | 12.97%623.39M | 24.35%2.27B | 24.73%569.22M | 23.60%542.01M | 24.30%606.97M | 24.48%551.84M | -4.57%1.83B | 18.47%456.36M | -17.63%438.51M | -4.06%488.32M |
| -Fees and commissions | 19.79%154.09M | 4.01%590.19M | 2.11%154.67M | 7.68%151.76M | 8.65%155.12M | -2.72%128.64M | 10.66%567.42M | 24.02%151.48M | 8.10%140.94M | 12.86%142.77M |
| -Including:Fees and commission income | 15.33%187.64M | 5.88%719.51M | 0.07%183.97M | 10.15%185.03M | 11.94%187.82M | 1.71%162.7M | 13.48%679.56M | 25.10%183.84M | 14.00%167.99M | 12.61%167.78M |
| -Including:Fees and commission expense | -1.49%33.55M | 15.32%129.33M | -9.46%29.3M | 23.01%33.28M | 30.76%32.7M | 22.82%34.06M | 30.26%112.15M | 30.43%32.36M | 59.37%27.05M | 11.18%25.01M |
| -Dividend income | 697.83%24.61M | 18.57%59.49M | 356.06%19.27M | 121.21%19.92M | 1.34%17.21M | -84.55%3.08M | -44.87%50.17M | -82.83%4.23M | -70.14%9.01M | -8.98%16.98M |
| -Gain loss on sale of securities | 11.40%421.59M | 25.82%1.39B | 28.73%379.38M | 1.65%295.3M | 16.57%335.93M | 64.12%378.45M | 2.40%1.1B | 28.75%294.71M | 0.28%290.5M | -5.09%288.17M |
| -Net reversal of impairment loss of financial instruments | 228.80%492K | -130.13%-292K | -185.00%-228K | -36.65%605K | -184.16%-287K | -295.90%-382K | 639.69%969K | 19.19%-80K | 629.01%955K | -155.19%-101K |
| -Total other operating income | -75.60%28.81M | 94.03%291.87M | 60.56%21.12M | 579.09%93.77M | -47.97%56.59M | 150.08%118.09M | -9.37%150.43M | 138.67%13.15M | -121.58%-19.57M | 0.01%108.75M |
| Credit losses provision | 371.09%37.52M | -235.85%-383.31M | 110.09%3.14M | -1,409.55%-398.82M | 178.52%4.42M | 115.62%7.96M | -199.29%-114.13M | -321.24%-31.09M | -169.76%-26.42M | -121.88%-5.62M |
| Operating expense | -3.07%573.32M | 5.53%2.35B | 0.10%596.36M | 3.18%567.27M | 7.63%594.79M | 11.90%591.45M | 3.70%2.23B | 5.90%595.76M | 1.37%549.8M | 5.56%552.63M |
| Staff costs | 1.52%341.85M | 3.79%1.33B | -2.69%329.76M | 5.49%338.46M | 2.42%328.13M | 10.63%336.72M | 6.77%1.28B | 1.08%338.86M | 6.07%320.83M | 14.27%320.39M |
| Selling and administrative expenses | -16.37%92.09M | 20.27%448.58M | 16.00%123.78M | 0.72%88.92M | 32.77%118.34M | 42.07%110.11M | 1.68%372.97M | 22.81%106.71M | -4.02%88.28M | -8.49%89.13M |
| -Selling and marketing expense | -28.66%42.14M | 31.38%237.69M | 35.24%70.97M | -1.91%40.19M | 40.23%67.47M | 50.06%59.06M | -7.68%180.92M | 17.76%52.48M | -15.98%40.97M | -9.45%48.11M |
| -General and administrative expense | -2.15%49.95M | 9.81%210.89M | -2.61%52.82M | 3.00%48.73M | 24.02%50.87M | 33.82%51.05M | 12.42%192.05M | 28.12%54.23M | 9.47%47.31M | -7.33%41.02M |
| Depreciation and amortization | -5.41%49.05M | -5.38%204.26M | -6.53%49.92M | -6.70%50.42M | -4.28%52.06M | -4.05%51.86M | -0.34%215.89M | -0.03%53.41M | 2.01%54.04M | -0.81%54.39M |
| -Depreciation | -9.90%31.59M | -9.02%135.26M | -10.72%32.51M | -11.27%32.95M | -7.33%34.73M | -6.85%35.06M | -6.20%148.67M | -3.81%36.42M | -4.00%37.13M | -7.81%37.48M |
| -Amortization | 3.97%17.46M | 2.66%69M | 2.44%17.41M | 3.34%17.47M | 2.50%17.33M | 2.35%16.8M | 15.63%67.22M | 9.19%17M | 18.28%16.91M | 19.29%16.91M |
| Rent and land expenses | 2.94%3.95M | -5.82%15.73M | -3.85%4.09M | -13.80%3.49M | 1.29%4.31M | -7.34%3.84M | 3.65%16.7M | 3.58%4.26M | -3.55%4.04M | 4.55%4.25M |
| Insurance and claims | -33.16%8.64M | -17.77%44.24M | -88.99%1.45M | 14.22%16.6M | -3.20%13.26M | 4.53%12.93M | 18.60%53.8M | 2.29%13.2M | 20.84%14.53M | 25.80%13.7M |
| Other operating expenses | 2.29%77.73M | 7.44%304M | 10.12%87.35M | 1.93%69.4M | 11.18%78.69M | -0.16%75.99M | -5.46%282.94M | 13.31%79.32M | -13.54%68.08M | -6.83%70.77M |
| Income from associates and other participating interests | -16.95%311.1M | -7.77%1.47B | -8.83%366.6M | -15.62%324.15M | -10.71%400.18M | 5.67%374.59M | 23.22%1.59B | 18.78%402.13M | 22.76%384.18M | 20.15%448.16M |
| Special income (charges) | 675.00%31K | -4,658.20%-398.48M | -99.91%6K | -1,374,196.55%-398.49M | 0 | -98.80%4K | 3,651.93%8.74M | 345,450.00%6.91M | 2,800.00%29K | 29,280.00%1.47M |
| Less:Other special charges | -675.00%-31K | 4,658.20%398.48M | 99.91%-6K | 1,374,196.55%398.49M | ---- | 98.80%-4K | -3,651.93%-8.74M | -345,450.00%-6.91M | -2,800.00%-29K | -29,280.00%-1.47M |
| Other non-operating income (expenses) | -2.21%2.26M | ---- | ---- | ---- | ---- | 162.73%2.31M | ---- | ---- | ---- | ---- |
| Income before tax | 0.87%1.35B | 4.40%5.36B | 5.96%1.36B | -0.49%1.26B | 4.45%1.4B | 7.74%1.34B | 10.97%5.13B | 23.20%1.28B | 14.09%1.27B | 4.16%1.34B |
| Income tax | 4.27%260.08M | 15.87%1.09B | 8.79%269.57M | 40.92%315.49M | -0.24%252.43M | 16.90%249.42M | 16.03%938.04M | 41.03%247.79M | 23.17%223.87M | 3.17%253.02M |
| Net income | 0.09%1.09B | 1.84%4.27B | 5.28%1.09B | -9.36%946.7M | 5.54%1.15B | 5.84%1.09B | 9.90%4.2B | 19.58%1.03B | 12.32%1.04B | 4.39%1.09B |
| Net income continuous operations | 0.09%1.09B | 1.84%4.27B | 5.28%1.09B | -9.36%946.7M | 5.54%1.15B | 5.84%1.09B | 9.90%4.2B | 19.58%1.03B | 12.32%1.04B | 4.39%1.09B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 0.09%1.09B | 1.84%4.27B | 5.28%1.09B | -9.36%946.7M | 5.54%1.15B | 5.84%1.09B | 9.90%4.2B | 19.58%1.03B | 12.32%1.04B | 4.39%1.09B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 0.09%1.09B | 1.84%4.27B | 5.28%1.09B | -9.36%946.7M | 5.54%1.15B | 5.84%1.09B | 9.90%4.2B | 19.58%1.03B | 12.32%1.04B | 4.39%1.09B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 0.00%0.532 | 1.86%2.085 | 5.15%0.531 | -9.41%0.462 | 5.46%0.56 | 5.77%0.532 | 9.82%2.047 | 19.67%0.505 | 12.33%0.51 | 4.32%0.531 |
| Diluted earnings per share | 0.00%0.529 | 1.27%2.073 | 4.76%0.528 | -10.00%0.459 | 4.90%0.557 | 5.38%0.529 | 9.88%2.047 | 19.43%0.504 | 12.33%0.51 | 4.32%0.531 |
| Dividend per share | 0 | 12.70%0.71 | 0 | 12.00%0.28 | 13.16%0.43 | 0 | 8.62%0.63 | 0 | 19.05%0.25 | 2.70%0.38 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.